Tadataka (Tachi) Yamada likes to hire employees who have moved around the world, but he's no stranger to change himself. Since beginning his career as a physician–scientist, he has headed up research and development at GlaxoSmithKline and has directed The Bill & Melinda Gates Foundation's Global Health Program. In 2012, he returned to industry to take up a position as Takeda's Chief Medical and Scientific Officer. He's bringing change with him, both to Takeda and to the Japanese pharmaceutical industry, he tells Asher Mullard.
This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Tachi Yamada. Nat Rev Drug Discov 12, 658–659 (2013). https://doi.org/10.1038/nrd4110
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4110
- Springer Nature Limited